胃切除术后辅助剂capecitabine加oxaliplatin (CAPOX) 与S-1的比较:使用全国索赔数据库进行基于人口的队列研究

Chi Hoon Maeng1, Hoseob Kim2, Mina Kim2

  • 1Division of Medical Oncology-Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, (02447) 23 Kyungheedaero, Dongdaemun-gu, Seoul, South Korea. mchihoon@khu.ac.kr.

Scientific reports
|October 11, 2023
PubMed
概括

对于接受胃切除术的胃癌患者,S-1辅助化疗与capecitabine加oxaliplatin (CAPOX) 相比,显示出更高的生存结果. 这项研究表明,在特定的临床场景中,S-1可能是首选的选择.